PMID- 21592983 OWN - NLM STAT- MEDLINE DCOM- 20110808 LR - 20240317 IS - 1537-6613 (Electronic) IS - 0022-1899 (Print) IS - 0022-1899 (Linking) VI - 203 IP - 11 DP - 2011 Jun 1 TI - Human leukocyte antigen genotypes in the genetic control of adaptive immune responses to smallpox vaccine. PG - 1546-55 LID - 10.1093/infdis/jir167 [doi] AB - BACKGROUND: The role of human leukocyte antigen (HLA) genes in mediating adaptive immune responses to smallpox vaccine remains unknown. METHODS: We determined genotypes for a group of individuals (n = 1071) who received a single dose of smallpox vaccine (Dryvax, Wyeth Laboratories) and examined associations between HLA alleles and 15 immune outcomes to smallpox vaccine on a per-locus and a per-allele level. RESULTS: We found significant associations between the HLA-B and HLA - DQB1 loci and vaccinia-induced antibodies (P = .04 for each locus), with the HLA-B*1302 (P = .036), B*3802 (P = .011), DQB1*0302 (P = .015), and DQB1*0604 (P = .017) alleles being associated with higher levels. Significant global associations were identified between vaccinia-specific interferon (IFN)-gamma and DQA1 (P = .003), interleukin (IL)-1beta and HLA-B (P = .004), tumor necrosis factor (TNF)-alpha and HLA-B (P = .006), and IL-6 and HLA-B locus (P = .016) for secreted cytokines, as well as between CD8alpha(+) IFN-gamma Elispot responses and DQB1 (P = .027). Subjects carrying B*3906 (P = .006) and B*5701 (P < .001) secreted higher levels of IL-1beta than did subjects who did not carry these alleles. Subjects carrying the B*5301 (P = .047) and B*5601 (P = .008) alleles secreted less IL-1beta, compared with subjects who did not carry these alleles. The B*3502 (P = .009), B*5601 (P = .004), and B*5701 (P < .001) alleles were significantly associated with variations in TNF-alpha secretion. CONCLUSIONS: These data suggest that variations in antibody and cellular IFN-gamma, IL-1beta, TNF-alpha, and IL-6 immune responses after receipt of smallpox vaccine are genetically controlled by HLA genes or genes in close linkage disequilibrium to these alleles. FAU - Ovsyannikova, Inna G AU - Ovsyannikova IG AD - Mayo Clinic Vaccine Research Group, Mayo Clinic, Rochester, Minnesota 55905, USA. FAU - Vierkant, Robert A AU - Vierkant RA FAU - Pankratz, V Shane AU - Pankratz VS FAU - Jacobson, Robert M AU - Jacobson RM FAU - Poland, Gregory A AU - Poland GA LA - eng PT - Journal Article PT - Research Support, N.I.H., Extramural PL - United States TA - J Infect Dis JT - The Journal of infectious diseases JID - 0413675 RN - 0 (Antibodies, Viral) RN - 0 (Cytokines) RN - 0 (DryVax vaccine) RN - 0 (HLA Antigens) RN - 0 (Smallpox Vaccine) RN - 0 (Tumor Necrosis Factor-alpha) RN - 82115-62-6 (Interferon-gamma) SB - IM MH - Adaptive Immunity/*genetics/immunology MH - Adolescent MH - Adult MH - Antibodies, Viral/blood/immunology MH - Cytokines/blood/*immunology/metabolism MH - Enzyme-Linked Immunospot Assay MH - Female MH - HLA Antigens/*genetics/immunology MH - Humans MH - Interferon-gamma/blood/immunology MH - Linear Models MH - Male MH - Multivariate Analysis MH - Smallpox Vaccine/administration & dosage/*immunology MH - Tumor Necrosis Factor-alpha/blood/immunology PMC - PMC3096794 EDAT- 2011/05/20 06:00 MHDA- 2011/08/09 06:00 PMCR- 2012/06/01 CRDT- 2011/05/20 06:00 PHST- 2011/05/20 06:00 [entrez] PHST- 2011/05/20 06:00 [pubmed] PHST- 2011/08/09 06:00 [medline] PHST- 2012/06/01 00:00 [pmc-release] AID - jir167 [pii] AID - 10.1093/infdis/jir167 [doi] PST - ppublish SO - J Infect Dis. 2011 Jun 1;203(11):1546-55. doi: 10.1093/infdis/jir167.